{
    "id": "dbpedia_8099_1",
    "rank": 67,
    "data": {
        "url": "https://www.bioworld.com/articles/499472-simcere-launches-460m-ipo-in-hong-kong-shares-drops-24",
        "read_more_link": "",
        "language": "en",
        "title": "Simcere launches $460M IPO in Hong Kong, shares drops 24%",
        "top_image": "https://www.bioworld.com/ext/resources/Stock-images/Money/HKEX-exterior.png?height=635&t=1632868875&width=1200",
        "meta_img": "https://www.bioworld.com/ext/resources/Stock-images/Money/HKEX-exterior.png?height=635&t=1632868875&width=1200",
        "images": [
            "https://www.bioworld.com/images/Cortellis_Flagship_Logo.png",
            "https://www.bioworld.com/images/Cortellis_Flagship_Logo_TM_RGB_Color.png",
            "https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Ocular/Eye-with-digital-overlay.jpg?height=355&t=1717017591&width=640",
            "https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Musculoskeletal/Girl-in-wheelchair.png?height=355&t=1617737781&width=640",
            "https://www.bioworld.com/ext/resources/BMT-source/2022/05-31-Abbott-FreeStyle-Libre-3-Sensor-Smartphone.png?height=355&t=1654033980&width=640",
            "https://www.bioworld.com/ext/resources/Ads/2024/BioFuture-2024-banner-300x250.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "HKEX",
            "IPO",
            "Initial Public Offerings",
            "Simcere Pharmaceutical Co. Ltd."
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Chinese drugmaker Simcere Pharmaceutical Group Ltd. raised HK$3.57 billion ($460.6 million) in Hong Kong by issuing 261 million shares at HK$13.7 apiece on Oct 27. Its debut hit a setback, with its share price dropping over 20% in mid-morning and extending losses to nearly 24% to close at HK$10.46. Sponsored by Morgan Stanley and CICC, the IPO was oversubscribed by 590 times by the retail tranche. This is Simcereâ€™s second listing after its IPO in New York in 2007. It was the first Chinese pharmaceutical . . .",
        "meta_lang": "en",
        "meta_favicon": "/icons/apple-touch-icon.png",
        "meta_site_name": "",
        "canonical_link": "https://www.bioworld.com/articles/499472-simcere-launches-460m-ipo-in-hong-kong-shares-drops-24",
        "text": "Chinese drugmaker Simcere Pharmaceutical Group Ltd. raised HK$3.57 billion ($460.6 million) in Hong Kong by issuing 261 million shares at HK$13.7 apiece on Oct 27. Its debut hit a setback, with its share price (HKEX:2096) dropping over 20% in mid-morning and extending losses to nearly 24% to close at HK$10.46."
    }
}